Nalaganje...
Crizotinib-associated toxic epidermal necrolysis in an ALK-positive advanced NSCLC patient
Crizotinib is an oral small-molecule inhibitor of anaplastic lymphoma kinase (ALK) tyrosine-kinase that has been approved for treating patients with advanced echinoderm microtubule associated protein like 4-ALK rearranged non-small-cell lung cancer (NSCLC). Toxic epidermal necrolysis (TEN) is a rare...
Shranjeno v:
| izdano v: | Mol Clin Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5795818/ https://ncbi.nlm.nih.gov/pubmed/29456853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1553 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|